{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:54:01Z","timestamp":1765961641917,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007310","name":"Wuyi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neulet.2023.137166","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T02:02:44Z","timestamp":1678068164000},"page":"137166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"802","author":[{"given":"Rong","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Qiu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-8524","authenticated-orcid":false,"given":"Kin Yip","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137166_b0005","doi-asserted-by":"crossref","unstructured":"C. Ma, F. Hong, S. Yang, Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions, Molecules (Basel, Switzerland) 27 (2022).","DOI":"10.3390\/molecules27041210"},{"key":"10.1016\/j.neulet.2023.137166_b0010","doi-asserted-by":"crossref","unstructured":"A. Serrano-Pozo, M.P. Frosch, E. Masliah, B.T. Hyman, Neuropathological alterations in Alzheimer disease, Cold Spring Harb Perspect Med 1 (2011) a006189.","DOI":"10.1101\/cshperspect.a006189"},{"key":"10.1016\/j.neulet.2023.137166_b0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neulet.2023.137166_b0020","doi-asserted-by":"crossref","DOI":"10.5599\/admet.3.3.196","article-title":"The Roles of Genetics in A\u03b2 related Alzheimer's Diseases","volume":"3","author":"Tian","year":"2015","journal-title":"Admet & Dmpk"},{"key":"10.1016\/j.neulet.2023.137166_b0025","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.2174\/092986711797535245","article-title":"Multi-target-directed ligands in Alzheimer's disease treatment","volume":"18","author":"Bajda","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2023.137166_b0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neulet.2023.137166_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.11.010","article-title":"Inhibitors of NF-kappaB and P2X7\/NLRP3\/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease","volume":"326","author":"Thawkar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2023.137166_b0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer's disease","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2023.137166_b0045","doi-asserted-by":"crossref","unstructured":"Z. Breijyeh, R. Karaman, Comprehensive Review on Alzheimer's Disease: Causes and Treatment, Molecules (Basel, Switzerland) 25 (2020).","DOI":"10.3390\/molecules25245789"},{"key":"10.1016\/j.neulet.2023.137166_b0050","doi-asserted-by":"crossref","unstructured":"S. Srivastava, R. Ahmad, S.K. Khare, Alzheimer's disease and its treatment by different approaches: A review, Eur J Med Chem 216 (2021) 113320.","DOI":"10.1016\/j.ejmech.2021.113320"},{"issue":"6","key":"10.1016\/j.neulet.2023.137166_b0055","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s12031-022-02009-7","article-title":"Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease","volume":"72","author":"Pradhan","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.neulet.2023.137166_b0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.neulet.2023.137166_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41582-020-00454-9","article-title":"Aducanumab and the FDA - where are we now?","volume":"17","author":"Fillit","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2023.137166_b0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1568026619666190201153257","article-title":"Small Molecule Natural Products and Alzheimer's Disease","volume":"19","author":"Wu","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2023.137166_b0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/14728214.2020.1808621","article-title":"Anti-amyloid-beta protein agents for the treatment of Alzheimer's disease: an update on emerging drugs","volume":"25","author":"Lozupone","year":"2020","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.neulet.2023.137166_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1568026619666191203113745","article-title":"Progress in Target Drug Molecules for Alzheimer's Disease","volume":"20","author":"Xie","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2023.137166_b0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer's disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.neulet.2023.137166_b0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1570159X14666160119094820","article-title":"AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease","volume":"14","author":"Wang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neulet.2023.137166_b0095","doi-asserted-by":"crossref","unstructured":"B. Bargagna, L. Ciccone, S. Nencetti, M.A. Santos, S. Chaves, C. Camodeca, E. Orlandini, Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents, Molecules (Basel, Switzerland) 26 (2021).","DOI":"10.3390\/molecules26196015"},{"key":"10.1016\/j.neulet.2023.137166_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108354","article-title":"9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model","volume":"181","author":"Ju","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neulet.2023.137166_b0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ddr.21631","article-title":"Dual targeting of cholinesterase and amyloid beta with pyridinium\/isoquinolium derivatives","volume":"81","author":"Chakravarty","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.neulet.2023.137166_b0110","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/acschemneuro.0c00464","article-title":"An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid beta Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease","volume":"11","author":"Ju","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.neulet.2023.137166_b0115","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2174\/1389557521666211027104638","article-title":"A Review on the In Vitro Evaluation of the Anticholinesterase Activity Based on Ellman's Method","volume":"22","author":"de Almeida","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neulet.2023.137166_b0120","unstructured":"Jackson_Laboratory, 3\u00d7Tg-AD mice - MMRRC Strain #034830-JAX. 2022."},{"key":"10.1016\/j.neulet.2023.137166_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer's disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2023.137166_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship Between Amyloid-beta Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2023.137166_b0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.redox.2014.03.002","article-title":"Abeta and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E","volume":"2","author":"Giraldo","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.neulet.2023.137166_b0140","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/13\/3\/031001","article-title":"Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging","volume":"13","author":"Kaczanowski","year":"2016","journal-title":"Phys. Biol."},{"key":"10.1016\/j.neulet.2023.137166_b0145","doi-asserted-by":"crossref","unstructured":"F. Hernandez, J.J. Lucas, J. Avila, GSK3 and tau: two convergence points in Alzheimer's disease, Journal of Alzheimer's disease : JAD 33 Suppl 1 (2013) S141-144.","DOI":"10.3233\/JAD-2012-129025"},{"key":"10.1016\/j.neulet.2023.137166_b0150","first-page":"46","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2023.137166_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105149","article-title":"Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents","volume":"114","author":"Gao","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neulet.2023.137166_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/bs.pmbts.2019.07.003","article-title":"Restoring synaptic function through multimodal therapeutics","volume":"168","author":"Loera-Valencia","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137166_b0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: Targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neulet.2023.137166_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084145","article-title":"Chromeno[3,4-b]xanthones as First-in-Class AChE and Abeta Aggregation Dual-Inhibitors","volume":"22","author":"Malafaia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137166_b0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.neulet.2023.137166_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5195\/cajgh.2014.179","article-title":"Role of ROS in Abeta42 Mediated Activation of Cerebral Endothelial Cells","volume":"3","author":"Tsoy","year":"2014","journal-title":"Central Asian journal of global health"},{"key":"10.1016\/j.neulet.2023.137166_b0185","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bpa.12567","article-title":"Downregulated apoptosis and autophagy after anti-Abeta immunotherapy in Alzheimer's disease","volume":"28","author":"Paquet","year":"2018","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"10.1016\/j.neulet.2023.137166_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.05.038","article-title":"The neuroprotective effect of the GSK-3beta inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice","volume":"320","author":"Ahn","year":"2012","journal-title":"J. Neurol. Sci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:47:59Z","timestamp":1759625279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"alternative-id":["S0304394023001234"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137166","relation":{},"ISSN":["0304-3940"],"issn-type":[{"type":"print","value":"0304-3940"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137166"}}